Non-invasive Diagnosis of Ischemic Heart Disease

HyperQ Resting


Chest pain is one of the main reasons for hospital emergency department visits worldwide. Early risk stratification of patients presenting with chest pain and suspected acute myocardial schaemia or infarction is a major clinical challenge.

Resting 12-lead ECGs, a mainstay in the management of acute myocardial ischaemia, are limited by low sensitivity, especially in cases of non-ST elevation myocardial infarction and unstable angina.

HyperQ™ Resting is available with the following products: CARDIOVIT CS-200 Excellence and CS-200 Touch


  • HyperQ Resting provides high accuracy, early detection and superior diagnostic value
  • Extracts additional, previously unseen data from a 3-minute resting rhythm recording
  • Suitable for emergency departments, emergency medical services, primary care clinics and telemedicine services



Device availability in your market is subject to regulatory approval.